BBIO returns by year
BridgeBio Pharma Inc. has returned +16.7% annually (CAGR) since 2020. Calendar-year, monthly and weekly total returns for BridgeBio Pharma Inc. (BBIO) below, through August 13, 2026 — the most recent year is year-to-date.
BridgeBio Pharma Inc. returns by year (2020–2026)#
Calendar-year returns with each year's path and its dividend contribution (dividend return = total minus price return).
| Year | Start price | End price | Path | Dividend | Total return |
|---|---|---|---|---|---|
| 2026YTD | $76.49 | $81.22 | +0.0% | +6.2% | |
| 2025 | $27.44 | $76.49 | +0.0% | +178.8% | |
| 2024 | $40.37 | $27.44 | +0.0% | -32.0% | |
| 2023 | $7.62 | $40.37 | +0.0% | +429.8% | |
| 2022 | $16.68 | $7.62 | +0.0% | -54.3% | |
| 2021 | $71.11 | $16.68 | +0.0% | -76.5% | |
| 2020 | $35.05 | $71.11 | +0.0% | +102.9% |
Total return by period
Methodology#
Returns are total returns (dividends reinvested), computed from BBIO's split- and dividend-adjusted closes. The bar chart switches between annual and monthly periods. Annualized return is the compound annual growth rate over the full period. The current year is year-to-date. See also the periodic table of returns. Past performance does not predict future returns; not investment advice.
See also: S&P 500 · Nasdaq-100 · Dow Jones · Russell 2000 · US Bond Market · Gold · Silver · Bitcoin · Ethereum
FAQ#
- What is BridgeBio Pharma Inc.'s average annual return?
- Since 2020, BridgeBio Pharma Inc. (BBIO) has returned about 16.7% a year (the compound annual growth rate) and an average calendar-year return of 91.4%.
- What were BridgeBio Pharma Inc.'s best and worst years?
- Over 2020–2026, the best year was 2023 (+429.8%) and the worst was 2021 (-76.5%).
- How often is BridgeBio Pharma Inc. up in a year?
- 3 of the 6 full years since 2020 were positive — about 50% of the time.